Tech Company Financing Transactions
MBF Therapeutics Funding Round
On 2/8/2013, MBF Therapeutics raised $50 thousand in investment from Ben Franklin Technology Partners.
Transaction Overview
Company Name
Announced On
2/8/2013
Transaction Type
Venture Equity
Amount
$50,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
640 Woodbrook Dr.
Ambler, PA 19002
USA
Ambler, PA 19002
USA
Phone
Website
Email Address
Overview
MBF Therapeutics (MBFT), a veterinary oncology company, is advancing the quality of cancer care for companion animals with innovative and humane therapies for the treatment of dogs and cats with cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Tillett
Chief Marketing Officer
Carl Johnson
Chief Scientific Officer
Lorraine Kelle
VP - Bus. Development
Ron Cravens
Browse more venture capital transactions:
Prev: 2/8/2013: Parkmobile venture capital transaction
Next: 2/8/2013: Spire venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs